Citation Impact
Citing Papers
Safety and Efficacy of Lamivudine-Zidovudine Combination Therapy in Antiretroviral-Naive Patients
1996
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Mucosal Innate Immune Factors in the Female Genital Tract Are Associated with Vaginal HIV-1 Shedding Independent of Plasma Viral Load
2006
Rape and subsequent seroconversion to HIV.
1990
Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms.
2017 Standout
Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine
1996
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
2011 Standout
A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter
1996
Contribution of platelets to tumour metastasis
2011 Standout
Switching constant domains enhances agonist activities of antibodies to a thrombopoietin receptor
2007
Eltrombopag for Thrombocytopenia in Patients with Cirrhosis Associated with Hepatitis C
2007
Adherence to Antiretroviral and Pneumocystis Prophylaxis in HIV Disease
1998
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
1996
Painful and non‐painful neuropathy in HIV‐infected patients: an analysis of somatosensory nerve function
2003
Core Structure of gp41 from the HIV Envelope Glycoprotein
1997 Standout
Lamivudine or Stavudine in Two- and Three-Drug Combinations against Human Immunodeficiency Virus Type 1 Replication In Vitro
1996
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 Standout
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1997 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Cancer nanotechnology: opportunities and challenges
2005 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
In vivo cancer targeting and imaging with semiconductor quantum dots
2004 Standout
Cytokine Mechanisms of Central Sensitization: Distinct and Overlapping Role of Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α in Regulating Synaptic and Neuronal Activity in the Superficial Spinal Cord
2008 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
1997 Standout
Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura
2007
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
1998 Standout
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
1999 Standout
Chronic hepatitis B
2007 Standout
Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms
2005
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Thermo- and pH-responsive polymers in drug delivery☆
2006 Standout
A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 Protease
1995
Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients
1999
Mutation in Hbv Rna–Dependent Dna Polymerase Confers Resistance to Lamivudine In Vivo
1996
Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter
1995
The Use of a Sensitive Equilibrium Dialysis Method for the Measurement of Free Testosterone Levels in Healthy, Cycling Women and in Human Immunodeficiency Virus-Infected Women1
1998
Antagonism between Human Immunodeficiency Virus Type 1 Protease Inhibitors Indinavir and Saquinavir In Vitro
1997
Biobehavioral responses to stress in females: Tend-and-befriend, not fight-or-flight.
2000 Standout
Immune thrombocytopenic purpura in adults
2007
Designing dendrimers for biological applications
2005 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
1998
Efficient synthesis of 3,3-diheteroaromatic oxindole analogues and their in vitro evaluation for spermicidal potential
2009
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
2009
Evaluation of antiretrovirals in animal models of HIV infection
2009
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
The dawning era of polymer therapeutics
2003 Standout
Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)
1995
Glial activation: a driving force for pathological pain
2001
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
1996
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
2000 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
The Causes of Esophageal Symptoms in Human Immunodeficiency Virus Infection
1991
Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro
1997
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance
1998 StandoutScience
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Antiretroviral drugs for AIDS
1996
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease
1997 StandoutScience
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450
1996
No safe haven: Male violence against women at home, at work, and in the community.
1994
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
The Unenlarged Lymph Nodes of HIV-1–infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly Active Antiretroviral Therapy
1998 StandoutNobel
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors
2008
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
1999 Standout
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
2008
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
Whither or Wither Microbicides?
2008 Science
Association of Saquinavir Plasma Concentrations with Side Effects but Not with Antiretroviral Outcome in Patients Infected with Protease Inhibitor-Susceptible Human Immunodeficiency Virus Type 1
2007
Mechanism by which the lectin actinohivin blocks HIV infection of target cells
2009 StandoutNobel
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
2010 Standout
Historical review: megakaryopoiesis and thrombopoiesis
2008
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
1997 StandoutScience
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Comparative In Vitro Sensitivities of Human Immune Cell Lines, Vaginal and Cervical Epithelial Cell Lines, and Primary Cells to Candidate Microbicides Nonoxynol 9, C31G, and Sodium Dodecyl Sulfate
2002
Concept and classification of dystonia.
1988
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus
2016 StandoutNobel
Works of V. S. Kitchen being referenced
Epstein-Barr virus associated oesophageal ulcers in AIDS.
1990
Safety Study of Nonoxynol-9 as a Vaginal Microbicide: Evidence of Adverse Effects
1998
Rape and subsequent seroconversion to HIV.
1989
Evaluation of Safety and Efficacy of 3TC (Lamivudine) in Patients with Asymptomatic or Mildly Symptomatic Human Immunodeficiency Virus Infection: A Phase I/II Study
1995
A Placebo-controlled, Double-blind Prospective Study in Healthy Female Volunteers of Dextrin Sulphate Gel:
1997
`Chemical condoms’ for the prevention of HIV infection: evaluation of novel agents against SHIV89.6PDin vitro and in vivo
2001
Safety and activity of saquinavir in HIV infection
1995
Nonoxynol-9 in Lubricated Condoms
1996
An Oral, Non-Petide, Small Molecule Thrombopoietin Receptor Agonist Increases Platelet Counts in Healthy Subjects.
2004
Rape and HIV
1991
Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist
2007
Menstrual symptoms in women infected by the human immunodeficiency virus.
1994
A Study of Neuropathy in HIV Infection
1992